AVALON GLOBOCAR/SH SH (AVCO) & Its Peers Head-To-Head Contrast

AVALON GLOBOCAR/SH SH (OTCMKTS: AVCO) is one of 26 publicly-traded companies in the “Management consulting services” industry, but how does it compare to its rivals? We will compare AVALON GLOBOCAR/SH SH to related businesses based on the strength of its institutional ownership, analyst recommendations, profitability, dividends, valuation, risk and earnings.

Earnings & Valuation

This table compares AVALON GLOBOCAR/SH SH and its rivals gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
AVALON GLOBOCAR/SH SH $1.08 million -$3.46 million -55.00
AVALON GLOBOCAR/SH SH Competitors $993.84 million $66.10 million 15.15

AVALON GLOBOCAR/SH SH’s rivals have higher revenue and earnings than AVALON GLOBOCAR/SH SH. AVALON GLOBOCAR/SH SH is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Volatility & Risk

AVALON GLOBOCAR/SH SH has a beta of -5.43, meaning that its stock price is 643% less volatile than the S&P 500. Comparatively, AVALON GLOBOCAR/SH SH’s rivals have a beta of 0.63, meaning that their average stock price is 37% less volatile than the S&P 500.

Insider & Institutional Ownership

65.4% of shares of all “Management consulting services” companies are owned by institutional investors. 75.0% of AVALON GLOBOCAR/SH SH shares are owned by company insiders. Comparatively, 10.6% of shares of all “Management consulting services” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.


This table compares AVALON GLOBOCAR/SH SH and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
AVALON GLOBOCAR/SH SH -365.09% -81.16% -44.88%
AVALON GLOBOCAR/SH SH Competitors -18.21% -37.44% -2.73%

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for AVALON GLOBOCAR/SH SH and its rivals, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AVALON GLOBOCAR/SH SH Competitors 122 403 578 30 2.46

As a group, “Management consulting services” companies have a potential upside of 13.27%. Given AVALON GLOBOCAR/SH SH’s rivals higher possible upside, analysts clearly believe AVALON GLOBOCAR/SH SH has less favorable growth aspects than its rivals.


AVALON GLOBOCAR/SH SH rivals beat AVALON GLOBOCAR/SH SH on 9 of the 10 factors compared.


Avalon GloboCare Corp., together with its subsidiaries, engages in integrating and managing healthcare services and resources in the United States. It provides medical related consulting services and develops Avalon Cell and Avalon Rehab platforms that cover the areas of regenerative medicine, cell-based immunotherapy, and exosome technology, as well as rehabilitation medicine. The company also develops proprietary diagnostic and therapeutic products leveraging exosome technology; and markets and distributes proprietary exosome isolation systems and related products to hospitals, as well as provides development services for hospitals. In addition, it owns and operates real property. The company has a strategic partnership Weill Cornell Medical College to co-develop technologies and bio-production of chimeric antigen receptor-T Therapy. Avalon GloboCare Corp. is headquartered in Freehold, New Jersey.

Receive News & Ratings for AVALON GLOBOCAR/SH SH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AVALON GLOBOCAR/SH SH and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply